On ECHEMI
Home > Drugs > Shanxi JINXIN DOUBLE-CRANE Pharmaceutical Co., Ltd.

Shanxi JINXIN DOUBLE-CRANE Pharmaceutical Co., Ltd.

  • Founded in:

    2001-12-14
  • Country:

    China China
  • Address:

    Sanlidun, North of Xia County, Yuncheng City, Shanxi Province
  • Tax NO.:

    911408287281430205
  • Registered Funds:

    164.191 million yuan
  • Website:

  • Email:

Related Drugs
Clindamycin Phosphate Injection
Clindamycin phosphate.
Name Description Content CAS NO. Registered Holders
Clindamycin phosphate

This product is a chemically semi-synthetic clindamycin derivative. After entering the body, it is rapidly hydrolyzed into clindamycin to show pharmacological activity. The antibacterial spectrum, antibacterial activity and therapeutic effect are the same as those of clindamycin. The antibacterial effect is 4 to 8 times stronger than that of lincomycin. It has good absorption and high bone concentration, and has a good effect on anaerobic infections. It has strong antibacterial activity mainly against Gram-positive cocci (such as Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, Streptococcus pneumoniae, etc.) and anaerobic bacteria (such as Clostridium, Bacteroides, Clostridium, etc.).

More

This product is a chemically semi-synthetic clindamycin derivative. After entering the body, it is rapidly hydrolyzed into clindamycin to show pharmacological activity. The antibacterial spectrum, antibacterial activity and therapeutic effect are the same as those of clindamycin. The antibacterial effect is 4 to 8 times stronger than that of lincomycin. It has good absorption and high bone concentration, and has a good effect on anaerobic infections. It has strong antibacterial activity mainly against Gram-positive cocci (such as Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, Streptococcus pneumoniae, etc.) and anaerobic bacteria (such as Clostridium, Bacteroides, Clostridium, etc.).

24729-96-2 33
Compound Lophatherum gracile tablets Ⅰ
This product is a compound preparation, and its components per 1000 tablets include: 218.5g of Apocynum venetum leaves, 171.0g of wild chrysanthemum, 184.2g of Stephania tetrandra, 15.0g of magnesium trisilicate, 1.6g of hydralazine sulfate, 1.6g of hydrochlorothiazide, 1.05g of promethazine hydrochloride, 0.5g of vitamin B1, 0.5g of vitamin B6, and 0.25g of calcium pantothenate.
Name Description Content CAS NO. Registered Holders
Dogbane Leaf

Not mentioned separately

More

Not mentioned separately

218.5g 0
Chrysanthelandioum

Not mentioned separately

More

Not mentioned separately

171.0g 0
STEPHANIAE TETRANDRAE RADIX

Not mentioned separately

More

Not mentioned separately

184.2g 0
Magnesium trisilicate

Not mentioned separately

More

Not mentioned separately

15.0g 14987-04-3 11
Dihydralazine sulphate

Lowering blood pressure, anti-arrhythmic

More

Lowering blood pressure, anti-arrhythmic

1.6g 7327-87-9 9
Hydrochlorothiazide

Lowers blood pressure

More

Lowers blood pressure

1.6g 58-93-5 54
Promethazine hydrochloride

Reduces spontaneous activity and has a synergistic effect with sodium pentobarbital

More

Reduces spontaneous activity and has a synergistic effect with sodium pentobarbital

1.05g 58-33-3 29
Thiamine chloride

Not mentioned separately

More

Not mentioned separately

0.5g 59-43-8 9
Vitamin B6

Not mentioned separately

More

Not mentioned separately

0.5g 8059-24-3 13
Calcium D-Pantothenate

Not mentioned separately

More

Not mentioned separately

0.25g 137-08-6 8
Xiangdan injection
Salvia miltiorrhiza
Name Description Content CAS NO. Registered Holders
Salvia Root P.E Tanshinone IIA 20%

Anti-myocardial ischemia, improve hemodynamics, improve blood rheology, and alleviate experimental liver damage

More

Anti-myocardial ischemia, improve hemodynamics, improve blood rheology, and alleviate experimental liver damage

0
Dalbergiae odoriferae lignum

Anti-myocardial ischemia, improve hemodynamics, improve blood rheology, and alleviate experimental liver damage

More

Anti-myocardial ischemia, improve hemodynamics, improve blood rheology, and alleviate experimental liver damage

0
Xiangdan injection
Salvia miltiorrhiza
Name Description Content CAS NO. Registered Holders
Salvia Root P.E Tanshinone IIA 20%

Anti-myocardial ischemia, improve hemodynamics, improve blood rheology, and reduce liver damage

More

Anti-myocardial ischemia, improve hemodynamics, improve blood rheology, and reduce liver damage

0
Dalbergiae odoriferae lignum

Anti-myocardial ischemia, improve hemodynamics, improve blood rheology, and reduce liver damage

More

Anti-myocardial ischemia, improve hemodynamics, improve blood rheology, and reduce liver damage

0
Racemic Anisodamine Hydrochloride Injection
The main ingredient of this product is: racemic anisodamine hydrochloride. Its chemical name is: (±)-6β-hydroxy-1αH, 5αH-tropane-3α-ol tropate hydrochloride.
Name Description Content CAS NO. Registered Holders
Anisodamine

It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasms caused by acetylcholine, can also relieve microvascular spasms, improve microcirculation, relax gastrointestinal smooth muscle, and inhibit its peristalsis. Its effect is slightly weaker than atropine, and its effect of inhibiting digestive gland secretion is 1/10 of atropine. Its effect of inhibiting saliva secretion and dilating pupils is weaker, which is 1/20-1/10 of atropine. Because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than atropine.

More

It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasms caused by acetylcholine, can also relieve microvascular spasms, improve microcirculation, relax gastrointestinal smooth muscle, and inhibit its peristalsis. Its effect is slightly weaker than atropine, and its effect of inhibiting digestive gland secretion is 1/10 of atropine. Its effect of inhibiting saliva secretion and dilating pupils is weaker, which is 1/20-1/10 of atropine. Because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than atropine.

17659-49-3 6
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.